Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lysaght, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lysaght, M. J.
J Am Soc Nephrol 13:S37-S40, 2002
© 2002 American Society of Nephrology


Renal Replacement Therapy

Maintenance Dialysis Population Dynamics: Current Trends and Long-Term Implications

Michael J. Lysaght

Center for Biomedical Engineering, Brown University, Providence, Rhode Island.

Address correspondence to Dr. Michael J. Lysaght, Engineering and Medical Science, Brown University, Providence, RI 02818. Phone: 401-863-7512; Fax: 401-863-1753; E-mail: Lysaght{at}Brown.edu

Abstract

ABSTRACT. Despite a general recognition that treatment of end-stage renal disease (ESRD) has become a large-scale undertaking, the size of the treated population and the associated costs are not well quantified. This report combines data available from a variety of sources and places the current (midyear 2001) estimated global maintenance dialysis population at just over 1.1 million patients. The size of this population has been expanding at a rate of 7% per year. Total therapy cost per patient per year in the United States is approximately $66,000. Assuming that this figure is a reasonable global average, the annual worldwide cost of maintenance ESRD therapy in the year 2001, excluding renal transplantation, will be between $70 and $75 billion US dollars. If current trends in ESRD prevalence continue, as seems probable, the ESRD population will exceed 2 million patients by the year 2010. The care of this group represents a major societal commitment: the aggregate cost of treating ESRD during the coming decade will exceed $1 trillion, a thought-provoking sum by any economic metric.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
W.-C. Yang, S.-J. Hwang, and Taiwan Society of Nephrology
Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance
Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3977 - 3982.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Gaarkeuken, M. A. Siezenga, K. Zuidwijk, C. van Kooten, T. J. Rabelink, M. R. Daha, and S. P. Berger
Complement activation by tubular cells is mediated by properdin binding
Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1397 - F1403.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. M. Just, F. Th. de Charro, E. A. Tschosik, L. L. Noe, S. K. Bhattacharyya, and M. C. Riella
Reimbursement and economic factors influencing dialysis modality choice around the world
Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2365 - 2373.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Otero-Gonzalez, C. Perez-Melon, M. J. Camba, A. Iglesias, J. Bravo, E. Novoa, and E. Armada
Haemodialysis in satellite units outside the hospital
Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2434 - 2435.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. L. Davis, W. E. Harmon, J. Himmelfarb, T. Hostetter, N. Powe, P. Smedberg, L. A. Szczech, P. S. Aronson, and for the American Society of Nephrology Public Poli
World Kidney Day 2008: Think Globally, Speak Locally
J. Am. Soc. Nephrol., March 1, 2008; 19(3): 413 - 416.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. C. W. Tang, Y. W. Ho, A. W. C. Tang, Y. Y. Cheng, F. H. Chiu, W. K. Lo, K. N. Lai, and for the Hong Kong Peritoneal Dialysis Study Group
Delaying initiation of dialysis till symptomatic uraemia--is it too late?
Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1926 - 1932.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
L. H. Oterdoom, A. P. J. de Vries, R. T. Gansevoort, P. E. de Jong, R. O. B. Gans, S. J. L. Bakker, and for the PREVEND Study Group
Fasting insulin modifies the relation between age and renal function
Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1587 - 1592.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
A. L. Friedman, S. R. Geoghegan, N. M. Sowers, S. Kulkarni, and R. N. Formica Jr
Medication Errors in the Outpatient Setting: Classification and Root Cause Analysis
Arch Surg, March 1, 2007; 142(3): 278 - 283.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. Ejerblad, C. M. Fored, P. Lindblad, J. Fryzek, J. K. McLaughlin, and O. Nyren
Obesity and Risk for Chronic Renal Failure
J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1695 - 1702.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. C. Dash and S. K. Agarwal
Incidence of chronic kidney disease in India
Nephrol. Dial. Transplant., January 1, 2006; 21(1): 232 - 233.
[Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. C. Brodie and H. D. Humes
Stem Cell Approaches for the Treatment of Renal Failure
Pharmacol. Rev., September 1, 2005; 57(3): 299 - 313.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
P. H. Lin, R. L. Bush, L. Nguyen, M. A. Guerrero, C. Chen, and A. B. Lumsden
Anastomotic Strategies to Improve Hemodialysis Access Patency--A Review
Vascular and Endovascular Surgery, March 1, 2005; 39(2): 135 - 142.
[Abstract] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. Chiurchiu, G. Remuzzi, and P. Ruggenenti
Angiotensin-Converting Enzyme Inhibition and Renal Protection in Nondiabetic Patients: The Data of the Meta-Analyses
J. Am. Soc. Nephrol., March 1, 2005; 16(3_suppl_1): S58 - S63.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. Ejerblad, C. M. Fored, P. Lindblad, J. Fryzek, P. W. Dickman, C.-G. Elinder, J. K. McLaughlin, and O. Nyren
Association between Smoking and Chronic Renal Failure in a Nationwide Population-Based Case-Control Study
J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2178 - 2185.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Schieppati and G. Remuzzi
Fighting Renal Diseases in Poor Countries: Building a Global Fund with the Help of the Pharmaceutical Industry
J. Am. Soc. Nephrol., March 1, 2004; 15(3): 704 - 707.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
E. S. Antezano and M. Hong
Sudden Cardiac Death
J Intensive Care Med, November 1, 2003; 18(6): 313 - 329.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Schieppati, N. Perico, and G. Remuzzi
Preventing end-stage renal disease: the potential impact of screening and intervention in developing countries
Nephrol. Dial. Transplant., May 1, 2003; 18(5): 858 - 859.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP